KR20010105019A - Method for extracting phytosterol with high purity in a high yield - Google Patents
Method for extracting phytosterol with high purity in a high yield Download PDFInfo
- Publication number
- KR20010105019A KR20010105019A KR1020000026618A KR20000026618A KR20010105019A KR 20010105019 A KR20010105019 A KR 20010105019A KR 1020000026618 A KR1020000026618 A KR 1020000026618A KR 20000026618 A KR20000026618 A KR 20000026618A KR 20010105019 A KR20010105019 A KR 20010105019A
- Authority
- KR
- South Korea
- Prior art keywords
- phytosterol
- high purity
- extract
- added
- extracting
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 33
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims abstract description 54
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 40
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 31
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims abstract description 30
- 239000000284 extract Substances 0.000 claims abstract description 26
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims abstract description 24
- 239000012153 distilled water Substances 0.000 claims abstract description 16
- 239000012046 mixed solvent Substances 0.000 claims abstract description 9
- 230000002829 reductive effect Effects 0.000 claims abstract description 8
- 238000010992 reflux Methods 0.000 claims abstract description 6
- 239000006228 supernatant Substances 0.000 claims abstract description 6
- 238000001035 drying Methods 0.000 claims abstract description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 39
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 38
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims description 30
- 238000007127 saponification reaction Methods 0.000 claims description 28
- 239000002904 solvent Substances 0.000 claims description 20
- 229940068065 phytosterols Drugs 0.000 claims description 14
- 238000000605 extraction Methods 0.000 claims description 13
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 claims description 12
- 239000012670 alkaline solution Substances 0.000 claims description 7
- 239000003960 organic solvent Substances 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 5
- 210000004369 blood Anatomy 0.000 claims description 4
- 239000008280 blood Substances 0.000 claims description 4
- 238000005119 centrifugation Methods 0.000 claims description 4
- 238000010438 heat treatment Methods 0.000 claims description 4
- 230000002401 inhibitory effect Effects 0.000 claims description 4
- 208000008589 Obesity Diseases 0.000 claims description 3
- 235000020824 obesity Nutrition 0.000 claims description 3
- 238000012545 processing Methods 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 10
- 238000000926 separation method Methods 0.000 abstract description 10
- 239000000203 mixture Substances 0.000 abstract description 9
- 235000005911 diet Nutrition 0.000 abstract description 8
- 230000037213 diet Effects 0.000 abstract description 8
- 230000003579 anti-obesity Effects 0.000 abstract description 3
- 235000021067 refined food Nutrition 0.000 abstract description 3
- 239000013543 active substance Substances 0.000 abstract description 2
- 239000000654 additive Substances 0.000 abstract description 2
- 239000000706 filtrate Substances 0.000 abstract description 2
- 239000000843 powder Substances 0.000 abstract description 2
- 230000000996 additive effect Effects 0.000 abstract 1
- 235000013376 functional food Nutrition 0.000 abstract 1
- 230000001629 suppression Effects 0.000 abstract 1
- 241000700159 Rattus Species 0.000 description 33
- 238000004519 manufacturing process Methods 0.000 description 28
- 238000012360 testing method Methods 0.000 description 19
- 235000009200 high fat diet Nutrition 0.000 description 12
- 235000012000 cholesterol Nutrition 0.000 description 11
- 230000003247 decreasing effect Effects 0.000 description 10
- 241000196324 Embryophyta Species 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 8
- 210000002966 serum Anatomy 0.000 description 8
- 239000003513 alkali Substances 0.000 description 7
- 238000003965 capillary gas chromatography Methods 0.000 description 7
- 150000002632 lipids Chemical class 0.000 description 7
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 6
- 239000004480 active ingredient Substances 0.000 description 6
- 230000009469 supplementation Effects 0.000 description 6
- 235000021050 feed intake Nutrition 0.000 description 5
- 239000011259 mixed solution Substances 0.000 description 5
- 230000007935 neutral effect Effects 0.000 description 5
- 235000019786 weight gain Nutrition 0.000 description 5
- 108010023302 HDL Cholesterol Proteins 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 4
- 238000010171 animal model Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 150000003904 phospholipids Chemical class 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 230000004584 weight gain Effects 0.000 description 3
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 2
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 2
- SGNBVLSWZMBQTH-FGAXOLDCSA-N Campesterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@H](C(C)C)C)C)CC4)CC3)CC=2)CC1 SGNBVLSWZMBQTH-FGAXOLDCSA-N 0.000 description 2
- BTEISVKTSQLKST-UHFFFAOYSA-N Haliclonasterol Natural products CC(C=CC(C)C(C)(C)C)C1CCC2C3=CC=C4CC(O)CCC4(C)C3CCC12C BTEISVKTSQLKST-UHFFFAOYSA-N 0.000 description 2
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 description 2
- 229940076810 beta sitosterol Drugs 0.000 description 2
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- SGNBVLSWZMBQTH-PODYLUTMSA-N campesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](C)C(C)C)[C@@]1(C)CC2 SGNBVLSWZMBQTH-PODYLUTMSA-N 0.000 description 2
- 235000000431 campesterol Nutrition 0.000 description 2
- 235000007882 dietary composition Nutrition 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- DQYBDCGIPTYXML-UHFFFAOYSA-N ethoxyethane;hydrate Chemical compound O.CCOCC DQYBDCGIPTYXML-UHFFFAOYSA-N 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 231100001231 less toxic Toxicity 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 2
- 229950005143 sitosterol Drugs 0.000 description 2
- 238000013222 sprague-dawley male rat Methods 0.000 description 2
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 description 2
- 235000016831 stigmasterol Nutrition 0.000 description 2
- 229940032091 stigmasterol Drugs 0.000 description 2
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- HVYWMOMLDIMFJA-UHFFFAOYSA-N 3-cholesterol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCCC(C)C)C1(C)CC2 HVYWMOMLDIMFJA-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 239000004470 DL Methionine Substances 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 230000001906 cholesterol absorption Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 230000003031 feeding effect Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000008204 material by function Substances 0.000 description 1
- FFEARJCKVFRZRR-UHFFFAOYSA-N methionine Chemical compound CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 235000006109 methionine Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 239000012454 non-polar solvent Substances 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
- A23L5/51—Concentration
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12G—WINE; PREPARATION THEREOF; ALCOHOLIC BEVERAGES; PREPARATION OF ALCOHOLIC BEVERAGES NOT PROVIDED FOR IN SUBCLASSES C12C OR C12H
- C12G3/00—Preparation of other alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/332—Promoters of weight control and weight loss
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/14—Extraction
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/24—Heat, thermal treatment
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/50—Concentrating, enriching or enhancing in functional factors
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Organic Chemistry (AREA)
- Botany (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Mycology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Steroid Compounds (AREA)
Abstract
본 발명은 생리활성물질의 하나인 파이토스테롤(phytosterol)의 고순도 분리방법에 관한 것이다. 보다 상세하게는 건조된 오갈피를 세절한 후 에탄올을 세절된 오갈피 중량에 대해 약 10배 첨가하고 환류냉각기가 부착된 추출장치를 이용하여 60∼80℃의 온도에서 약 6시간 추출한다. 추출된 여과물에 대하여 30수산화 칼륨 또는 수산화 나트륨 용액을 3∼5첨가하여 50∼70℃의 온도로 약 1시간 가열처리한다. 이어서 감압농축하여 알코올을 제거한 후 증류수와 헥산의 비율이 약 2:1이 되도록 혼합된 용매를 첨가하여 약 10분간 진탕혼합하고 원심분리하여 상등액만을 취한다. 상기 추출물을 감압농축 및 건조함으로서 연한 갈색의 파이토스테롤 분말을 고수율, 고순도로 생산할 수 있으며, 상기 과정을 통해 얻어진 파이토스테롤은 혈중 콜레스테롤 수치의 상승 억제 효과는 물론 비만억제 효과를 나타내어 고칼로리 가공식품 및 다이어트 등의 기능성 식품류의 첨가물로 유용하게 이용될 수 있다.The present invention relates to a high purity separation method of phytosterol, which is one of physiologically active substances. More specifically, after the dried organolpi is chopped, ethanol is added about 10 times to the weight of the organolpi sliced and extracted for about 6 hours at a temperature of 60 to 80 ℃ using an extractor equipped with a reflux cooler. 30-5 potassium hydroxide or sodium hydroxide solution was added to the extracted filtrate and heat-treated at 50-70 degreeC for about 1 hour. Subsequently, the mixture was concentrated under reduced pressure to remove alcohol, and then a mixed solvent was added so that the ratio of distilled water and hexane was about 2: 1. Then, the mixture was shaken for about 10 minutes and centrifuged to take only the supernatant. By concentrating and drying the extract under reduced pressure, a light brown phytosterol powder can be produced in high yield and high purity. The phytosterol obtained through the above process has a high calorie suppression effect as well as an anti-obesity effect, resulting in high calorie processed foods. And it can be usefully used as an additive of functional foods such as diet.
Description
본 발명은 생리활성물질의 하나인 파이토스테롤(phytosterol)의 고순도 분리방법에 관한 것이다.The present invention relates to a high purity separation method of phytosterol, which is one of physiologically active substances.
파이토스테롤(phytosterol)은 천연 콜레스테롤 억제제(cholesterol-stopper)라고도 불리는 물질로서 동물의 생체 내에서 혈중 콜레스테롤 수치를 낮추는데 탁월한 효과가 있는 것으로 알려져 있다. 식물체로부터 유효성분의 분리 및 그 효과에 대한 연구보고는 광범위하게 보고된 바 있으나, 파이토스테롤의 분리, 정제에 관해 직접적으로 연구된 사례는 매우 드문 상태이다.Phytosterol, also known as a natural cholesterol-stopper, is known to have an excellent effect on lowering blood cholesterol levels in animals. Research reports on the separation and effect of active ingredients from plants have been widely reported, but very few cases have been directly studied on the separation and purification of phytosterols.
현재까지 식물체로부터 유효성분의 분리 및 생산을 위하여 적용된 기술의 대부분은 단일 용매를 사용함으로써 순도가 낮은 조화합물(crude chemicals)을 추출, 분리하는 것이 주종을 이뤄 왔다. 그러나, 이러한 조추출물들은 순도가 낮기 때문에 그 효과가 미흡하여 용도에 제한을 받거나 소비자의 욕구를 충족시키지 못하였고, 이로 인해 새로운 수요 창출에 실패하여 왔다. 즉, 기존의 천연물로부터 유용한 화합물을 얻는 방법은 열수추출 또는 메탄올, 에탄올, 부탄올, 클로로포름, 에틸 에테르 등의 극성 또는 비극성 용매를 사용하여 각종 식물체로부터 추출하는 것이다.To date, most of the technologies applied for the separation and production of active ingredients from plants have been mainly extracted and separated from crude chemicals of low purity by using a single solvent. However, these crude extracts have a low purity and thus have insufficient effects, thus limiting their use or satisfying consumer's needs, thus failing to create new demand. That is, a method of obtaining a useful compound from existing natural products is by hot water extraction or extraction from various plants using a polar or nonpolar solvent such as methanol, ethanol, butanol, chloroform, ethyl ether and the like.
이에 본 발명자들은 생리활성 기능을 가진 유효성분의 하나인 파이토스테롤을 1차 추출한 후, 파이토스테롤이 검화되지 않는 성질을 이용하여 추출물에 검화 공정을 도입하고 이를 최적화하였을 뿐 아니라 특정 용매를 사용하여 추출물에 포함된 불순물을 제거함으로써 고순도의 파이토스테롤을 선별적으로 회수할 수 있음을 확인하고, 또한 생산된 파이토스테롤이 콜레스테롤의 흡수를 저해함과 더불어 비만억제에도 효과가 있음을 확인함으로써 본 발명을 완성하였다.Therefore, the inventors of the present invention first extracted phytosterol, which is one of the active ingredients having a physiologically active function, and then introduced the saponification process to the extract using the property that the phytosterol was not saponified, and optimized the extract as well as using a specific solvent. Completion of the present invention by confirming that high purity phytosterols can be selectively recovered by removing impurities contained in the present invention, and that the produced phytosterols inhibit cholesterol absorption and are effective in inhibiting obesity. It was.
본 발명은 상기한 실정을 감안하여 고순도 파이토스테롤의 효율적 생산방법을 개발하고자 한 것으로서, 원료인 오갈피에 대하여 각 단계별 용매 및 첨가물의 종류와 량, 반응조건 등에 관하여 연구하였으며, 추출된 물질의 효능에 관하여는 실험동물을 공시하여 그 효과를 조사하였다.The present invention is to develop an efficient production method of high-purity phytosterol in view of the above situation, and studied the type and amount of each step of solvent and additives, reaction conditions, etc. for the raw material ogalpi, and the efficacy of the extracted material In this regard, the experimental animals were disclosed and their effects were investigated.
상기 목적을 달성하기 위하여, 본 발명은 1차적으로 유기 용매로 가열 추출하고, 추출물에 알칼리 용액을 첨가하여 검화공정을 거치며, 증류수와 특정 유기 용매의 혼합 용매를 이용하여 재추출하는 것을 특징으로 하는 식물체로부터 파이토스테롤을 고순도로 추출하는 방법을 제공한다.In order to achieve the above object, the present invention is primarily heat extraction with an organic solvent, an alkaline solution is added to the extract and subjected to the saponification process, characterized in that the re-extraction using a mixed solvent of distilled water and a specific organic solvent Provided is a method for extracting phytosterols from plants in high purity.
구체적으로, 본 발명의 파이토스테롤의 고순도 추출방법은Specifically, the high purity extraction method of phytosterol of the present invention
1) 건조, 세절된 식물체에 유기 용매를 첨가하여 가열 추출하는 단계;1) heating extraction by adding an organic solvent to the dried, shredded plants;
2) 추출물에 알칼리 용액을 첨가하여 가열 처리하여 검화키는 단계;2) adding an alkaline solution to the extract and heat treating the extract;
3) 감압농축하여 알콜을 제거하는 단계;3) concentration under reduced pressure to remove alcohol;
4) 헥산, 메틸 에테르, 에틸 에테르 중에서 선택되는 하나 이상의 용매와 증류수의 혼합 용매를 첨가하여 진탕 혼합하는 단계; 및4) shaking mixing by adding a mixed solvent of one or more solvents selected from hexane, methyl ether and ethyl ether with distilled water; And
5) 원심분리하여 상등액을 얻는 단계를 포함한다.5) centrifugation to obtain a supernatant.
본 발명의 파이토스테롤 추출방법을 적용할 수 있는 식물체로는 오갈피(AcanthopanacisCortex Radicis)가 바람직하나, 이에 한정되는 것은 아니며 일반적으로 파이토스테롤 함량이 높은 것으로 알려진 식물체라면 모두 사용할 수 있다.As a plant to which the phytosterol extracting method of the present invention can be applied, Acanthopanacis Cortex Radicis is preferable, but is not limited thereto. In general, any plant known to have a high phytosterol content may be used.
상기에서, 단계 1의 유기 용매는 메탄올 또는 에탄올인 것이 바람직하다. 에탄올과 메탄올을 사용할 경우, 헥산, 부탄올, 에틸 에테르, 메틸 에테르, 클로로포름, 증류수와 같이 일반적으로 식물의 유효성분 추출에 사용되는 용매를 사용한 경우에 비해 추출물의 생산 수율은 물론 추출물 중의 파이토스테롤 함량에 있어서도 약 2배 이상의 높은 효과를 나타낸다.In the above, the organic solvent of step 1 is preferably methanol or ethanol. In the case of using ethanol and methanol, the production yield of the extract as well as the phytosterol content of the extract is higher than in the case of using a solvent generally used for extracting the active ingredients of plants such as hexane, butanol, ethyl ether, methyl ether, chloroform, and distilled water Also, the effect is about 2 times higher.
바람직하게는, 단계 1은 메탄올 또는 에탄올을 시료 중량에 대해 약 10배 첨가하고, 환류 냉각기가 부착된 추출 장치를 이용하여 60∼80℃의 온도에서 약 6시간 추출함으로써 고순도의 파이토스테롤을 추출할 수 있다.Preferably, step 1 is to extract high purity phytosterol by adding about 10 times methanol or ethanol to the sample weight and extracting about 6 hours at a temperature of 60 ~ 80 ℃ using an extraction device equipped with a reflux condenser. Can be.
한편, 단계 2의 알칼리 용액은 수산화 칼륨 또는 수산화 나트륨인 것이 바람직하며, 상기 검화 공정은 알칼리 용액을 3∼5 중량첨가하여 50∼70℃에서 약 1시간 동안 가열함으로써 이루어지는 것이 바람직하다.On the other hand, the alkaline solution of step 2 is preferably potassium hydroxide or sodium hydroxide, and the saponification process is preferably made by adding 3 to 5 weight of the alkaline solution and heating at 50 to 70 ° C. for about 1 hour.
보다 바람직하게는, 단계 2의 검화 공정은 30수산화 칼륨 용액을 추출물에 대해 약 5 중량첨가하고 약 60℃의 온도에서 약 1시간 동안 가열 처리하는 것이파이토스테롤의 생산 수율 및 순도 면에서 유리하다.More preferably, the saponification process of step 2 is advantageous in terms of production yield and purity of phytosterol, by adding about 5 weight percent of potassium hydroxide solution to the extract and heat-processing at a temperature of about 60 ° C. for about 1 hour.
알칼리의 첨가량이 증가할수록 생산 수율은 감소하는 경향을 나타내나, 파이토스테롤 함량은 비슷하거나 증가하는 경향을 나타낸다. 또한 검화 온도가 높아질수록 생산 수율은 증가하는 경향을 나타낸다.The production yield tends to decrease as the amount of alkali added increases, but the phytosterol content tends to be similar or increase. Also, as the saponification temperature increases, the production yield tends to increase.
한편, 단계 4의 혼합 용매로는 메틸 에테르:증류수, 에틸 에테르:증류수 또는 헥산:증류수의 비율이 1:1∼1:3인 것을 사용하는 것이 바람직하며, 혼합 용매는 시료 중량에 대해 약 5배 첨가하여 약 10분간 진탕 혼합하는 것이 바람직하다. 이때 에틸 에테르가 메틸 에테르에 비해 효과가 높지만, 헥산에 비해서는 파이트스테롤 함량은 낮은 것으로 조사되었다.On the other hand, as the mixed solvent of step 4, the ratio of methyl ether: distilled water, ethyl ether: distilled water or hexane: distilled water is preferably 1: 1 to 1: 3, and the mixed solvent is about 5 times the sample weight. It is preferred to add and shake for about 10 minutes. Although ethyl ether is more effective than methyl ether, it has been found that the content of phytosterol is lower than that of hexane.
본 발명의 고순도 파이토스테롤 추출방법은, 추가적으로 원심분리하여 얻어진 상등액을 감압농축 및 건조하는 과정을 포함할 수도 있다.The high purity phytosterol extraction method of the present invention may further include a step of concentrating and drying the supernatant obtained by centrifugation under reduced pressure.
이하 본 발명을 상세히 설명한다.Hereinafter, the present invention will be described in detail.
시료는 오갈피(AcanthopanacisCortex Radicis)를 사용하였으며 수분 7이하로 건조된 상태의 것을 크기 2cm 이하로 세절하여 표 1에서와 같이 헥산 등 8종의용매를 각각 시료량의 10배액 첨가하고 80℃에서 6시간 동안 환류냉각기가 부착된 추출장치를 이용하여 유효성분을 1차적으로 추출하였다. 그 결과 에탄올과 메탄올을 이용하여 추출하였을 때 각각 7.2, 7.3로서 가장 높은 수율을 나타내었으며 추출물 중에 함유된 파이토스테롤을 모세관 가스 크로마토그래피(capillary GC)로 확인한 결과 모두 38로서 가장 높게 나타났다. 그러나 에탄올이 메탄올에 비하여 독성이 약하므로 메탄올을 1차 추출 용매로 선정하였다. 추출된 추출물로부터 파이토스테롤을 제외한 기타 불순물을 제거하기 위하여, 파이토스테롤이 일종의 식물성 스테롤(sterol)류이므로 검화되지 않는 성질을 이용하여 검화공정을 도입함으로써 파이토스테롤의 정제를 시도하였다.The sample was used as Acanthopanacis Cortex Radicis, and the dried product was dried at a moisture of 7 or less and cut into 2 cm or less in size. As shown in Table 1, 8 kinds of solvents, such as hexane, were added 10 times the amount of each sample and 6 hours at 80 ° C. The active ingredient was first extracted using an extractor equipped with a reflux condenser. As a result, when extracted with ethanol and methanol, the highest yield was 7.2 and 7.3, respectively. The phytosterol contained in the extract was confirmed to be 38 as capillary gas chromatography (capillary GC). However, because ethanol is less toxic than methanol, methanol was selected as the primary extraction solvent. In order to remove other impurities except phytosterol from the extracted extract, an attempt was made to purify phytosterol by introducing a saponification process using properties that are not saponified since phytosterol is a kind of vegetable sterols.
기본적인 공정으로서 1차 용매추출물에 대하여 30NaOH 혹은 KOH용액을 용액의 양을 달리하여 첨가한 후 80℃의 온도 조건하에서 1시간씩 검화시켰다. 검화 후에는 검화되지 않은 파이토스테롤의 분리를 위하여 물과 에틸 에테르(ethyl ether)가 1:1로 혼합된 용매를 시료량의 5배 첨가하여 10분간 진탕혼합한 후 원심분리하여 에틸 에테르 층을 취한 다음, 농축, 건조하여 파이토스테롤 생산물을 얻었다. 각 공정별 시험이 진행되면서 결정된 최적조건은 다음 공정에서 채택하면서 공정별 최적조건을 결정하였다.As a basic process, 30 NaOH or KOH solution was added to the primary solvent extract by varying the amount of solution, and then saponified at 80 ° C. for 1 hour. After saponification, in order to separate phytosterol which is not saponified, a solvent mixed with water and ethyl ether 1: 1 is added 5 times of the sample volume, shake-mixed for 10 minutes, and centrifuged to take an ethyl ether layer. , Concentrated and dried to give the phytosterol product. The optimum conditions determined by the test of each process were adopted in the next process to determine the optimum conditions for each process.
검화에 의해 파이토스테롤 외 기타 물질을 제거하는 방식으로서 파이토스테롤의 정제 시험을 위하여 검화에 필요한 알칼리로는 30의 NaOH와 KOH를 사용하였다. 각 첨가량별로 생산수율과 파이토스테롤 함량을 측정한 결과 표 2에서와 같이 나타났다. 알카리의 첨가량이 많아짐에 따라 생산수율은 감소하는 경향이었으며 파이토스테롤의 함량은 30NaOH를 사용할 경우 3수준으로 첨가하였을 때 가장 높았고, 30KOH를 사용하였을 때는 5수준으로 첨가하였을 때 가장 높았다.As a method of removing phytosterol and other substances by saponification, NaOH and KOH of 30 were used as an alkali necessary for saponification for the purification test of phytosterol. As a result of measuring the production yield and phytosterol content for each addition amount was shown in Table 2. As the amount of alkali increased, the production yield tended to decrease. The content of phytosterol was the highest when added at 3 levels with 30 NaOH and the highest when added at 5 levels with 30 KOH.
검화법에 의한 파이토스테롤 분리시 검화온도에 따른 추출물의 생산수율과 파이토스테롤 함량을 측정한 결과 표 3에서와 같이 나타났다. 검화온도가 높아짐에 따라 생산수율도 높아지는 경향이었으나 파이토스테롤 함량은 60℃ 이상에는 경우 3수준으로 첨가하였을 때 가장 높았으며 30KOH를 사용하였을 때는 5수준으로 첨가하였을 때 가장 높았다.As a result of measuring the yield and phytosterol content of the extract according to the saponification temperature during the separation of phytosterol by the saponification method was shown in Table 3. As the saponification temperature increased, the production yield also tended to increase, but the phytosterol content was the highest when added at the 3rd level at 60 ℃ or higher, and the highest when added at the 5th level when 30KOH was used.
따라서 30KOH의 첨가량을 1차 용매추출물에 대하여 5첨가하는 것으로 결정하였다. 또한 검화시의 반응온도를 결정하기 위하여 40℃부터 90℃까지의 범위 하에서 시험한 결과 60℃에서 1시간 동안 검화시켰을 경우 파이토스테롤의 함량이 85로 가장 높게 나타났다. 그러나 생산수율은 반응온도가 높을수록 증가하는 경향이었다. 따라서 검화시의 반응조건은 60℃에서 1시간 동안 시험처리하는 것으로 결정하였다. 검화된 물질은 물과 에틸 에테르가 1:1로 혼합된 용매를 시료량의 5배를 첨가하여 10분간 진탕혼합한 후 원심분리하여 제거하고 에틸 에테르 층을 취한 후 농축, 건조하여 파이토스테롤 생산물을 얻었다. 에틸 에테르와 물의 혼합용액을 통한 파이토스테롤의 분리공정을 보다 효율적으로 개선하기 위하여 에틸 에테르, 메틸 에테르 및 헥산 등을 이용하여 물과 혼합용액을 비율별로 조정하여 시험한 결과 표 4에서와 같이 나타났다. 에틸 에테르가 메틸 에테르에 비해서는 효과가 높았으나 헥산에 비해서는 파이토스테롤 함량이 낮아 생산수율과 파이토스테롤 함량을 고려하여 헥산과 물의 비율이 1:2가 되도록 조절된 혼합용액을 최종배합비로 결정하였으며 이때의 생산수율은 1.8, 파이토스테롤 함량은 92이었다. 파이토스테롤의 주요 조성은 모세관 가스 크로마토그래피(Supelco사의 model No. SAC-5)로 확인한 결과 캄페스테롤(campesterol) 59, 스티그마스테롤(stigmasterol) 23, β-시토스테롤(β-sitosterol) 10및 기타 8로 구성된 것으로 나타났다.Therefore, it was determined that the addition amount of 30KOH was added to the primary solvent extract 5. In addition, in order to determine the reaction temperature at the time of the saponification test in the range of 40 ℃ to 90 ℃ when the saponification for 1 hour at 60 ℃ was the highest content of phytosterol 85. However, production yield tended to increase with higher reaction temperature. Therefore, the reaction conditions during saponification were determined to be tested at 60 ° C. for 1 hour. The saponified material was shaken for 10 minutes by adding 5 times the amount of sample to a solvent mixed with water and ethyl ether, and then centrifuged and removed. The ethyl ether layer was taken, concentrated and dried to obtain a phytosterol product. . In order to more efficiently improve the separation process of phytosterol through the mixed solution of ethyl ether and water, the result of testing by adjusting the ratio of water and mixed solution by using ethyl ether, methyl ether and hexane was shown as in Table 4. Ethyl ether was more effective than methyl ether, but the phytosterol content was lower than that of hexane. Thus, the mixed solution was adjusted to a ratio of hexane and water of 1: 2 in consideration of production yield and phytosterol content. The production yield at this time was 1.8, phytosterol content was 92. The main composition of phytosterols was determined by capillary gas chromatography (Supelco's model No. SAC-5), resulting in campesterol 59, stigmasterol 23, β-sitosterol 10 and other 8 It appeared to consist.
생산된 파이토스테롤의 생체 기능성을 조사하기 위하여 동물시험을 실시한 결과는 다음과 같다. 실험동물은 4주령의 스프래그-다우리(Sprague-Dawley) 웅성 쥐 49마리를 실험시작 전 일반 고형사료(삼양사)로 예비사육 후 체중이 평균 325±5g의 것을 4주간 본 시험에 사용하였다. 본 시험은 표 5와 같이 7마리 씩 5군으로 나누었다. 즉 고지방 식이(표 6)와 물을 급여한 대조구와, 시험구로는 물과 더불어 파이토스테롤 추출물을 각각 0.5mg, 1.0mg, 3.0mg, 5.0mg, 7.0mg, 9.0mg 씩 급여한 급여군으로 나누었으며 사육실의 온도는 22±2℃, 습도 60전후, 12시간 주기로 명암을 조절하였고 물과 사료는 자유롭게 섭취케 하였다.The results of animal tests to investigate the biofunctionality of the phytosterol produced are as follows. For the experimental animals, 49 Sprague-Dawley male rats of 4 weeks old were used as general solid feed (Samyang) before the experiment, and the average weight of 325 ± 5g was used for this test for 4 weeks. The test was divided into five groups of seven animals as shown in Table 5. In other words, the control group fed the high fat diet (Table 6) and water, and the test group divided the water and the phytosterol extract into the pay group fed 0.5 mg, 1.0 mg, 3.0 mg, 5.0 mg, 7.0 mg, and 9.0 mg, respectively. The temperature of the feeding room was 22 ± 2 ℃, humidity was around 60, and the contrast was controlled every 12 hours. Water and feed were freely consumed.
실험식이를 4주간 급여한 흰쥐의 체중 증가량, 사료 섭취량, 사료 효율은 표 7에서 나타난 바와 같다. 체중 증가량에 있어서는 파이토스테롤 급여량이 증가할수록 감소하였으며, 파이토스테롤을 3mg/100g rat/day 수준 이상 급여하였을 때 유의성 있는 감소 경향을 나타내었다. 사료 섭취량은 파이토스테롤 급여에 따른 유의적인 차이가 없었으며 사료 효율은 파이토스테롤을 3mg/100g rat/day 수준 이상 급여하였을 때 대조구 등에 비하여 유의성 있게 낮았다. 한편 실험식이를 4주간 급여한 흰쥐의 혈청지질 함량을 조사한 결과 표 8과 같이 나타났다. 혈청 중의 중성지질은 파이토스테롤의 급여량이 증가할수록 낮아졌으며 중성지질이 저하되는 파이토스테롤의 최소 농도는 1mg/100g rat/day 이었다. 혈청 중의 총콜레스테롤 함량은 파이토스테롤을 투여함에 따라서 저하되었으며 유의성이 인정되는 최소 농도는 1mg/100g rat/day 이었다.Weight gain, feed intake, and feed efficiency of the rats fed the experimental diet for 4 weeks are shown in Table 7. Body weight gain decreased with increasing phytosterol supplementation, and significantly decreased when phytosterol was fed over 3mg / 100g rat / day. Feed intake was not significantly different according to phytosterol supplementation, and feed efficiency was significantly lower than control group when phytosterol was fed more than 3mg / 100g rat / day. The serum lipid content of rats fed the experimental diet for 4 weeks was shown in Table 8. Neutral lipids in serum decreased with increasing phytosterol supplementation, and the minimum concentration of phytosterols in which neutral lipids decreased was 1mg / 100g rat / day. Total cholesterol content in serum decreased with administration of phytosterol, and the minimum level of significance was 1 mg / 100 g rat / day.
HDL-콜레스테롤 함량은 고지방 식이와 물을 급여한 대조구에 비해서 파이토스테롤을 급여한 시험구가 높게 나타났으며 1mg/100g rat/day 이상 급여하였을 때에 유의성 있게 향상되었다. 혈청 중의 인지질 함량은 파이토스테롤의 급여수준이 높을수록 증가되었으며 1mg/100g rat/day 이상 급여하였을 때 유의성 있게 증가되었다. 총콜레스테롤에 대한 총콜레스테롤과 HDL-콜레스테롤의 차이량으로 나타내는 RFI(risk factor index)는 대조구가 0.45인데 비하여 9mg/100g rat/day 수준으로 급여하였을 때 0.09로 현저하게 낮은 값을 나타내었다. RFI수치의 유의적인 변화는 파이토스테롤의 급여수준이 1mg/100g rat/day 이상일 경우 확인되었다. 따라서 파이토스테롤 추출물을 흰쥐에 급여하였을 때 비만억제 효과와 혈중 콜레스테롤 수치의 상승억제 효과를 나타내는 시험항목별 최소 농도는 각각 3mg/100g rat/day, 1mg/100g rat/day 로 나타났다.The HDL-cholesterol content was higher in the diet fed phytosterol compared to the control fed high fat diet and water, and significantly improved when fed 1 mg / 100 g rat / day or more. Serum phospholipid content increased with higher levels of phytosterol and significantly increased when fed more than 1 mg / 100 g rat / day. The risk factor index (RFI), which is the difference between total cholesterol and HDL-cholesterol to total cholesterol, was significantly lower (0.09) when fed at 9 mg / 100 g rat / day compared to 0.45. Significant changes in RFI levels were identified when phytosterol levels were above 1 mg / 100 g rats / day. Therefore, when the phytosterol extract was administered to rats, the minimum concentrations of the test items showing the anti-obesity effect and the synergistic inhibitory effect of blood cholesterol level were 3mg / 100g rat / day and 1mg / 100g rat / day, respectively.
이하 실시예에 의하여 본 발명을 상세히 설명한다.Hereinafter, the present invention will be described in detail with reference to Examples.
단, 하기 실시예는 본 발명을 예시하는 것으로, 본 발명의 범위가 이에 한정되지 않음은 당업자에게 자명할 것이다.However, the following examples illustrate the present invention, and the scope of the present invention is not limited thereto.
<실시예 1> 오갈피로부터 파이토스테롤의 추출Example 1 Extraction of Phytosterol from Ogalpi
건조된 오갈피(수분 4이하) 1kg을 크기 2cm이하로 세절하여 에탄올을 오갈피 중량에 대해 10배 첨가하고 환류냉각기가 부착된 추출장치를 이용하여 80℃의 온도에서 6시간 추출하였다. 추출된 여과물에 대하여 30수산화 칼륨 용액을 5첨가하여 60℃의 온도로 1시간 가열처리 하였다. 이어서 감압농축하여 알코올을 제거한 후 증류수와 헥산의 비율이 2:1이 되도록 혼합된 용매를 시료중량에 대해 5배 첨가하여 10분간 진탕혼합하고 원심분리하여 상등액을 취하였다. 이렇게 추출물을 감압농축 및 건조함으로서 연한 갈색의 파이토스테롤 분말 18g을 생산할 수 있었다.1 kg of dried organolpi (water 4 or less) was cut to a size of 2 cm or less and ethanol was added 10 times to the organolpi weight, and extracted at a temperature of 80 ° C. for 6 hours using an extractor equipped with a reflux condenser. 30 potassium hydroxide solution was added to the extracted filtrate and heat-treated at 60 ° C for 1 hour. Subsequently, the resultant was concentrated under reduced pressure to remove alcohol, and then a mixed solvent was added five times to the sample weight so that the ratio of distilled water and hexane was 2: 1. The mixture was shaken for 10 minutes and centrifuged to obtain a supernatant. The extract was concentrated under reduced pressure and dried to produce 18 g of a light brown phytosterol powder.
<실시예 2> 용매의 종류에 따른 파이토스테롤의 생산 수율 조사<Example 2> Production yield of phytosterol according to the type of solvent
수분 7이하로 건조된 상태의 오갈피(AcanthopanacisCortex Radicis)를 크기 2cm 이하로 세절하여 표 1에서와 같이 헥산 등 8종의 용매를 각각 시료량의 10배액 첨가하고 80℃에서 6시간 동안 환류냉각기가 부착된 추출장치를 이용하여 유효성분을 1차적으로 추출하였다. 그 결과를 하기 표 1에 나타내었다. 하기 표에서 생산 수율은 추출된 총고형물을 시료의 중량으로 나눈 뒤 100을 곱하여 계산하였고, 파이토스테롤의 함량은 모세관 가스 크로마토그래피를 통해 분석된 파이토스테롤의 총량으로부터 구하였다. 또한, 각각의 위첨자 a, b, c, d, e는 동일열 내 각기 다른 문자의 평균값은 유의차(p < 0.05)가 인정됨을 의미한다.Cut the Acanthopanacis Cortex Radicis dried to less than 7 cm in size to 2 cm or less, and add eight solvents, such as hexane, 10 times the sample volume, as shown in Table 1, and attach the reflux cooler at 80 ° C for 6 hours. The active ingredient was first extracted using the extracted extractor. The results are shown in Table 1 below. In the following table, the production yield was calculated by dividing the total solid extracted by the weight of the sample and multiplying by 100, and the content of phytosterol was obtained from the total amount of phytosterol analyzed by capillary gas chromatography. In addition, each of the superscripts a, b, c, d, and e means that a difference (p <0.05) is recognized for an average value of different characters in the same column.
그 결과 에탄올과 메탄올을 이용하여 추출하였을 때 각각 7.2, 7.3로서 가장 높은 수율을 나타내었으며 추출물 중에 함유된 파이토스테롤을 모세관 가스 크로마토그래피(capillary GC)로 확인한 결과 모두 38로서 가장 높게 나타났다. 그러나 에탄올이 메탄올에 비하여 독성이 약하므로 메탄올을 1차 추출 용매로 선정하였다.As a result, when extracted with ethanol and methanol, the highest yield was 7.2 and 7.3, respectively. The phytosterol contained in the extract was confirmed to be 38 as capillary gas chromatography (capillary GC). However, because ethanol is less toxic than methanol, methanol was selected as the primary extraction solvent.
<실시예 3> 알칼리의 종류와 첨가량에 따른 파이토스테롤의 생산 수율 조사<Example 3> Production yield of phytosterol according to the type and amount of alkali
검화에 의해 파이토스테롤 외 기타 물질을 제거하는 방식으로의 파이토스테롤의 정제 시험을 위하여 검화에 필요한 알칼리로서는 30의 NaOH와 KOH를 사용하였으며, 각 첨가량별로 생산수율과 파이토스테롤 함량을 측정한 결과 표 2에서와 같이 나타났다.For the purification test of phytosterol by the method of removing phytosterol and other substances by saponification, NaOH and KOH of 30 were used as the alkali required for saponification, and the production yield and phytosterol content were measured for each addition amount. Appeared as
상기 표에 나타난 바와 같이, 알카리의 첨가량이 많아짐에 따라 생산수율은 감소하는 경향이었으며 파이토스테롤의 함량은 30NaOH를 사용할 경우 3수준으로 첨가하였을 때 가장 높았고, 30KOH를 사용하였을 때는 5수준으로 첨가하였을 때 가장 높았다.As shown in the table, the production yield tended to decrease as the amount of alkali increased, and the content of phytosterol was the highest when added at 3 levels when 30 NaOH was used, and when added at 5 levels when 30 KOH was used. Highest.
<실시예 4> 검화 온도에 따른 파이토스테롤의 생산 수율 조사<Example 4> Production yield of phytosterol according to the saponification temperature
검화법에 의한 파이토스테롤 분리시 검화온도에 따른 추출물의 생산수율과 파이토스테롤 함량 변화를 조사하기 위하여 검화온도를 40, 50, 60, 70, 80 및 90℃로 달리 하여 실험한 결과를 하기 표 3에 나타내었다.In order to investigate the production yield and phytosterol content of extracts according to the saponification temperature during the separation of phytosterol by saponification method, the results of experiments varying the saponification temperature to 40, 50, 60, 70, 80 and 90 ° C. Shown in
그 결과, 검화온도가 높아짐에 따라 생산수율도 높아지는 경향이었으나 파이토스테롤 함량은 60℃ 이상에는 경우 3수준으로 첨가하였을 때 가장 높았으며, 30KOH를 사용하였을 때는 5수준으로 첨가하였을 때 가장 높았다.As a result, as the saponification temperature increased, the production yield tended to increase, but the phytosterol content was the highest when added at the 3 level at 60 ° C or higher, and the highest at the 5 level when 30 KOH was used.
따라서 30KOH의 첨가량을 1차 용매추출물에 대하여 5첨가하는 것으로 결정하였다. 또한 검화시의 반응온도를 결정하기 위하여 40℃부터 90℃까지의 범위 하에서 시험한 결과 60℃에서 1시간 동안 검화시켰을 경우 파이토스테롤의 함량이 85로 가장 높게 나타났다. 그러나 생산수율은 반응온도가 높을수록 증가하는 경향이었다. 따라서 검화시의 반응조건은 60℃에서 1시간 동안 시험처리하는 것으로 결정하였다.Therefore, it was determined that the addition amount of 30KOH was added to the primary solvent extract 5. In addition, in order to determine the reaction temperature at the time of the saponification test in the range of 40 ℃ to 90 ℃ when the saponification for 1 hour at 60 ℃ was the highest content of phytosterol 85. However, production yield tended to increase with higher reaction temperature. Therefore, the reaction conditions during saponification were determined to be tested at 60 ° C. for 1 hour.
<실시예 5> 검화물의 제거와 파이토스테롤 분리를 위한 용매의 혼합 비율에 따른 파이토스테롤의 생산 수율 조사<Example 5> Production yield of phytosterol according to the mixing ratio of the solvent for removal of the saponification and phytosterol separation
에틸 에테르와 물의 혼합용액을 통한 파이토스테롤의 분리공정을 보다 효율적으로 개선하기 위하여 에틸 에테르, 메틸 에테르 및 헥산 등을 이용하여 물과 혼합용액을 비율별로 조정하여 시험한 결과를 하기 표 4에 나타내었다.In order to more efficiently improve the separation process of phytosterol through the mixed solution of ethyl ether and water, the test results by adjusting the ratio of water and mixed solution by using ethyl ether, methyl ether, hexane, etc. are shown in Table 4 below. .
상기 결과로부터 알 수 있듯이, 에틸 에테르가 메틸 에테르에 비해서는 효과가 높았으나 헥산에 비해서는 파이토스테롤 함량이 낮아 생산수율과 파이토스테롤 함량을 고려하여 헥산과 물의 비율이 1:2가 되도록 조절된 혼합용액을 최종배합비로 결정하였으며, 이때의 생산수율은 1.8, 파이토스테롤 함량은 92이었다. 파이토스테롤의 주요 조성은 모세관 가스 크로마토그래피(Supelco사의 model No. SAC-5)로 확인한 결과 캄페스테롤(campesterol) 59, 스티그마스테롤(stigmasterol) 23, β-시토스테롤(β-sitosterol) 10및 기타 8로 구성된 것으로 나타났다.As can be seen from the above results, ethyl ether was more effective than methyl ether, but the phytosterol content was lower than hexane, so that the ratio of hexane and water was adjusted to 1: 2 in consideration of production yield and phytosterol content. The solution was determined as the final blending ratio, and the yield was 1.8 and the phytosterol content was 92. The main composition of phytosterols was determined by capillary gas chromatography (Supelco's model No. SAC-5), resulting in campesterol 59, stigmasterol 23, β-sitosterol 10 and other 8 It appeared to consist.
<실험예 1> 파이토스테롤의 생체 기능성 조사Experimental Example 1 Investigation of Biofunctionality of Phytosterols
실험동물은 4주령의 스프래그-다우리(Sprague-Dawley) 웅성 쥐 49마리를 실험시작 전 일반 고형사료(삼양사)로 예비사육 후 체중이 평균 325±5g의 것을 4주간 본 시험에 사용하였다. 본 시험은 표 5와 같이 7마리 씩 5군으로 나누었다. 즉 고지방 식이(표 6)와 물을 급여한 대조구와, 시험구로는 물과 더불어 파이토스테롤 추출물을 각각 0.5mg, 1.0mg, 3.0mg, 5.0mg, 7.0mg, 9.0mg 씩 급여한 급여군으로 나누었으며 사육실의 온도는 22±2℃, 습도 60전후, 12시간 주기로 명암을 조절하였고 물과 사료는 자유롭게 섭취케 하였다. 실험 식이 조성과 파이토스테롤 급여효과를 측정하기 위한 고지방 식이의 성분 조성을 각각 표 5 및 표 6에 나타내었다.For the experimental animals, 49 Sprague-Dawley male rats of 4 weeks old were used as general solid feed (Samyang) before the experiment, and the average weight of 325 ± 5g was used for this test for 4 weeks. The test was divided into five groups of seven animals as shown in Table 5. In other words, the control group fed the high fat diet (Table 6) and water, and the test group divided the water and the phytosterol extract into the pay group fed 0.5 mg, 1.0 mg, 3.0 mg, 5.0 mg, 7.0 mg, and 9.0 mg, respectively. The temperature of the feeding room was 22 ± 2 ℃, humidity was around 60, and the contrast was controlled every 12 hours. Water and feed were freely consumed. Table 5 and Table 6 show the composition of the high-fat diet for measuring the experimental dietary composition and phytosterol feeding effect, respectively.
실험 식이를 4주간 급여한 흰쥐의 체중 증가량, 사료 섭취량, 사료 효율은 표 7에서 나타난 바와 같다. 하기 표에서 모든 수치는 각각 흰쥐 7마리의 평균 수치를 나타낸다.Weight gain, feed intake and feed efficiency of the rats fed the experimental diet for 4 weeks are shown in Table 7. All values in the table below represent the mean values of 7 rats each.
체중 증가량에 있어서는 파이토스테롤 급여량이 증가할수록 감소하였으며 파이토스테롤을 3mg/100g rat/day 수준 이상 급여하였을 때 유의성 있는 감소 경향을 나타내었다. 사료 섭취량은 파이토스테롤 급여에 따른 유의적인 차이가 없었으며 사료 효율은 파이토스테롤을 3mg/100g rat/day 수준 이상 급여하였을 때 대조구 등에 비하여 유의성 있게 낮았다. 한편 실험식이를 4주간 급여한 흰쥐의 혈청지질 함량을 조사한 결과 표 8과 같이 나타났다.Body weight gain decreased with increasing phytosterol supplementation, and significantly decreased when phytosterol was fed over 3mg / 100g rat / day. Feed intake was not significantly different according to phytosterol supplementation, and feed efficiency was significantly lower than control group when phytosterol was fed more than 3mg / 100g rat / day. The serum lipid content of rats fed the experimental diet for 4 weeks was shown in Table 8.
* 단위 : mg/100mlUnit: mg / 100ml
* RFI(risk factor index) = (총콜레스테롤 - HDL 콜레스테롤)/총콜레스테롤* Risk factor index (RFI) = (Total Cholesterol-HDL Cholesterol) / Total Cholesterol
혈청 중의 중성지질은 파이토스테롤의 급여량이 증가할수록 낮아졌으며 중성지질이 저하되는 파이토스테롤의 최소 농도는 1mg/100g rat/day 이었다. 혈청 중의 총콜레스테롤 함량은 파이토스테롤을 투여함에 따라서 저하되었으며 유의성이 인정되는 최소 농도는 1mg/100g rat/day 이었다.Neutral lipids in serum decreased with increasing phytosterol supplementation, and the minimum concentration of phytosterols in which neutral lipids decreased was 1mg / 100g rat / day. Total cholesterol content in serum decreased with administration of phytosterol, and the minimum level of significance was 1 mg / 100 g rat / day.
HDL-콜레스테롤 함량은 고지방 식이와 물을 급여한 대조구에 비해서 파이토스테롤을 급여한 시험구가 높게 나타났으며 1mg/100g rat/day 이상 급여하였을 때에 유의성 있게 향상되었다. 혈청 중의 인지질 함량은 파이토스테롤의 급여수준이 높을수록 증가되었으며 1mg/100g rat/day 이상 급여하였을 때 유의성 있게 증가되었다. 총콜레스테롤에 대한 총콜레스테롤과 HDL-콜레스테롤의 차이량으로 나타내는 RFI(risk factor index)는 대조구가 0.45인데 비하여 9mg/100g rat/day 수준으로 급여하였을 때 0.09로 현저하게 낮은 값을 나타내었다. RFI수치의 유의적인 변화는 파이토스테롤의 급여수준이 1mg/100g rat/day 이상일 경우 확인되었다. 따라서 파이토스테롤 추출물을 흰쥐에 급여하였을 때 비만억제 효과와 혈중 콜레스테롤 수치의 상승억제 효과를 나타내는 시험항목별 최소 농도는 각각 3mg/100g rat/day, 1mg/100g rat/day 로 나타났다.The HDL-cholesterol content was higher in the diet fed phytosterol compared to the control fed high fat diet and water, and significantly improved when fed 1 mg / 100 g rat / day or more. Serum phospholipid content increased with higher levels of phytosterol and significantly increased when fed more than 1 mg / 100 g rat / day. The risk factor index (RFI), which is the difference between total cholesterol and HDL-cholesterol to total cholesterol, was significantly lower (0.09) when fed at 9 mg / 100 g rat / day compared to 0.45. Significant changes in RFI levels were identified when phytosterol levels were above 1 mg / 100 g rats / day. Therefore, when the phytosterol extract was administered to rats, the minimum concentrations of the test items showing the anti-obesity effect and the synergistic inhibitory effect of blood cholesterol level were 3mg / 100g rat / day and 1mg / 100g rat / day, respectively.
본 발명에 의하여 개발된 파이토스테롤의 생산기술은 오갈피 등 식물체로부터 기능성 소재인 파이토스테롤을 고순도의 상태로 경제성 있게 생산할 수 있는 새로운 방법이므로 파이토스테롤을 대량 생산 활용 할 수 있는 계기를 마련할 것으로 보인다.The production technology of phytosterols developed by the present invention is expected to provide an opportunity to mass-produce and utilize phytosterols because it is a new method that can economically produce phytosterols, which are functional materials, from plants such as organolpi in high purity.
개발된 파이토스테롤은 양념 불고기를 비롯한 가공식품류, 건강보조식품류 및 기타 음료, 주류 등에 다양하게 사용될 수 있을 것으로 사료된다. 특히 파이토스테롤의 이용은 콜레스테롤 저하 효과와 비만 억제 효과를 동시에 거둘 수 있어 육류를 비롯한 고칼로리 가공식품 및 다이어트 식품류에 첨가할 경우 커다란 수요창출 효과가 기대된다.The developed phytosterol may be used in a variety of processed foods such as seasoned bulgogi, health supplements and other beverages, alcoholic beverages. In particular, the use of phytosterol can have a cholesterol lowering effect and an obesity suppressing effect at the same time, so when it is added to high calorie processed foods and diet foods, it is expected to generate a great demand.
Claims (11)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020000026618A KR20010105019A (en) | 2000-05-18 | 2000-05-18 | Method for extracting phytosterol with high purity in a high yield |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020000026618A KR20010105019A (en) | 2000-05-18 | 2000-05-18 | Method for extracting phytosterol with high purity in a high yield |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20010105019A true KR20010105019A (en) | 2001-11-28 |
Family
ID=45813193
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020000026618A KR20010105019A (en) | 2000-05-18 | 2000-05-18 | Method for extracting phytosterol with high purity in a high yield |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20010105019A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100441641B1 (en) * | 2002-02-14 | 2004-07-23 | 학교법인 영광학원 | The physiological active materials from Acanthopanax sessiliflorus |
CN114280172A (en) * | 2021-12-06 | 2022-04-05 | 南京诺齐生物科技有限公司 | Detection and analysis method of phytosterol |
-
2000
- 2000-05-18 KR KR1020000026618A patent/KR20010105019A/en not_active Application Discontinuation
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100441641B1 (en) * | 2002-02-14 | 2004-07-23 | 학교법인 영광학원 | The physiological active materials from Acanthopanax sessiliflorus |
CN114280172A (en) * | 2021-12-06 | 2022-04-05 | 南京诺齐生物科技有限公司 | Detection and analysis method of phytosterol |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Caligiani et al. | Characterization of a potential nutraceutical ingredient: pomegranate (Punica granatum L.) seed oil unsaponifiable fraction | |
EP0783514B2 (en) | Sterol compositions from pulping soap | |
Määttä et al. | Phytosterol content in seven oat cultivars grown at three locations in Sweden | |
US5985344A (en) | Process for obtaining micronutrient enriched rice bran oil | |
CA2644152C (en) | Soybean-germ oil and method for the production of germ-enriched soybean material | |
PT1784087E (en) | Process of extracting citrus fiber from citrus vesicles | |
Hori et al. | Hypocholesterolemic effect of blue-green alga, ishikurage (Nostoc commune) in rats fed atherogenic diet | |
US8114447B2 (en) | Extraction of phytosterols from corn fiber using green solvents | |
EP1865792B1 (en) | Corn fiber hulls as a food additive or animal feed | |
KR20010105019A (en) | Method for extracting phytosterol with high purity in a high yield | |
Lee et al. | Effect of onion powder supplementation on lipid metabolism in high fat-cholesterol fed SD Rats | |
WO2011016558A1 (en) | Method for producing glucosylceramide-containing material | |
JP2646421B2 (en) | Obesity prevention agent | |
JP5821138B2 (en) | Cholesterol excretion enhancer and neutral fat excretion enhancer using sunflower inner stem fiber | |
INNAMI et al. | Water-soluble viscous substance of Jew's mellow leaves lowers serum and liver cholesterol concentrations and increases fecal steroid excretion in rats fed a high cholesterol diet | |
WO2006082437A1 (en) | Isolation and fractionation of waxes from plants | |
JP3319493B2 (en) | Slimming food | |
JP2001322934A (en) | Antioxidation composition containing rakanka glycoside having antioxidation action | |
KR101373493B1 (en) | Composition comprising Hizikia fusiformis for preventing and treating obesity or hyperlipidemia and atherosclerotic-vascular diseases | |
JPH0478264B2 (en) | ||
KR20070049465A (en) | Concentration of natural complex useful for the control of hypercholesterolemia and obesity and preparation thereof | |
Moreau et al. | Corn kernel oil and corn fiber oil | |
CN1240312C (en) | Body weight reducing health care product extrated from seaweed and its preparation method | |
JP2007197366A (en) | Lobo fruit-containing saponin and its use | |
KR20190102834A (en) | Manufacturing method of composition having anti-obesity and anti-diabetic activity using stem and leaf of Codonopsis lanceolata |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
N231 | Notification of change of applicant | ||
N231 | Notification of change of applicant | ||
WITN | Withdrawal due to no request for examination |